Clinical and immunogenetic characteristics of psoriatic arthritis: a single-center experience from South India
Keywords:
immunogenetic characteristics, psoriatic arthritis, CASPAR, HLA-B27, spondyloarthropathy, symmetricAbstract
Aim
The aim of this study was to determine the clinical characteristics and prevalence of HLA B27 in patients with psoriatic arthritis presenting to a tertiary care centre in South India.
Background
Although the prevalence of psoriasis is high in India, there is paucity of data, especially on Ps A.
Materials and methods
This retrospective study included 141 patients satisfying the ClASsification criteria for Ps A (CASPAR). Demographic, clinical, and laboratory data of the patients were collected through personal interviews, clinical examination, appropriate investigations, and analysis of case records. HLA-B27 typing by PCR method was done for all patients.
References
Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3:55-78.
Helliwell PS, Porter G, Taylor WJ, CASPAR Study Group. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis. 2007;66:113-117.
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H,et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis & Rheumatism. 2006; 54(8): 2665-2673.
Roberts MET, Wright V, Hill AGS, Mehra AC. Psoriatic arthritis: follow up study. Ann Rheum Dis. 1976;35:206-212.
Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C. Psoriatic arthritis: a clinical, immunological and radiological study of 180 patients. British J Rheumatol. 1991;30:245-250.
Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol. 1994;33:834-839.
Rajendran CP, Ledge SG, Rani KP, Madhavan R. Psoriatic arthritis. J Assoc Physicians India. 2003; 51:1065-1068.
Michet CJ, Mason TG, Mazlumzadeh M. Hip joint disease in psoriatic arthritis: risk factors and natural history. Ann Rheum Dis. 2005; 64:1068-1070.
Madland TM, Apalset EM, Johannessen AE, Rossebö B, Brun JG. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol. 2005; 32:1918-1922.
Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque type psoriasis. Br J Dermatol. 2009;160:1040-1047.
Zisman D, Eder L, Elias M, Laor A, Bitterman H, Rozenbaum M, et al. Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol. 2012;32(3):595-600.
Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis. An analysis of 220 patients. Q J Med. 1987;62:127-141.
Prasad PV, Bikku B, Kaviarasan PK, Senthilnathan A. A clinical study of psoriatic arthropathy. Indian Journal of Dermatology, Venereology and Leprology. 2007;73(3):166-70.
Rodriguez-Moreno J, Bonet M, Del Blanco-Barnusell J, Castaño C, Clavaguera T, Mateo-Soria L, et al. Mutilating/resorptive arthritis. a study of 24 patients in a series of 360 patients with psoriatic arthritis. Reumatol Clin. 2012 Dec 12 [Epub ahead of print]
Noosent JC, Gran JT. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand J Rheumatol. 2009;38:251-255.
Bond SJ, Farewell VT, Schentag CT, Gladman DD. Predictors for radiological damage in psoriatic arthritis: results from a single centre. Ann Rheum Dis. 2007; 66(3): 370-376.
Siannis F, Farewell VT, Cook RJ, Schentag CT, Gladman DD. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis. 2006; 65(4): 478-481.
Brockbank JE, Stein M, Schentag CT, Gladman DD. Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis. 2005 Feb;64(2):188-90.
Gladman DD, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford). 2011;50(1):25-31.
Thumboo J, Tham SN, Tay YK, Chee T, Mow B, Chia HP, et al. Patterns of psoriatic arthritis in orientals. J Rheumatol 1997;24:1949-53.
Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2012;71:50-55.
Queiro R, Torre JC, González S, López-Larrea C, Tinturé T, López-Lagunas I. HLA- antigens may influence the age of onset of psoriasis and psoriatic artritis. J Rheumatol. 2003;30:505-7.
Dalbeth N, Dockerty JL, Williamson L. Influence of HLA-B27 on the Clinical Presentation of Psoriatic Arthritis. J Rheumatol. 2003;30;2511.
Liao HT, Lin KC, Chang YT, Chen CH, Liang TH, Chen WS, et al. Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients. J Rheumatol. 2008; 35:891-5.
Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis. J Rheumatol. 2010;37;809-815.
Queiro R, Sarasqueta C, Belzunegui J, Gonzalez C, Figueroa M, Torre-Alonso JC. Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthritis Rheum. 2002; 31: 413 -18.
Bonfiglioli R, Conde RA, Sampaio-Barros PD, Louzada-Junior P, Donadi EA, Bertolo MB. Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritis. Clin Rheumatol. 2008; 27: 709- 12.
Brown MA. Genetics of ankylosing spondylitis. Curr Opin Rheumatol. 2010 ; 22 : 126- 32.
Zachariae H, Overgaard Peterson H, Kissmeyer Nielson F, Lamm L. HLA- antigens in pustular psoriasis. Dermatologica. 1977;154:73-7.
